Download PDF
Homœopathic Links 2022; 35(04): 251-259
DOI: 10.1055/s-0042-1755381
Original Article

Role of Homoeopathy in Managing Chronic Paronychia: A Pretest–Posttest Interventional Study

Gurudev Choubey 
1   Clinical Research Unit for Homoeopathy, Siliguri, under Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Siliguri, West Bengal, India
,
Laijun Nahar 
2   Regional Research Institute for Homoeopathy, Agartala, under Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Agartala, Tripura, India
,
Rajib Purkait 
1   Clinical Research Unit for Homoeopathy, Siliguri, under Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Siliguri, West Bengal, India
,
Abhiram Banerjee 
1   Clinical Research Unit for Homoeopathy, Siliguri, under Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Siliguri, West Bengal, India
,
Varanasi Roja 
3   Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, New Delhi, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background Chronic paronychia (CP), one of the commonest recalcitrant nail disorders, is a troublesome source of considerable discomfort to the patients, which negatively affects the quality of life (QoL) mainly of the housewives reporting in the Indian subcontinent.

Objective The aim of this study is to assess the utility of individualised homoeopathic treatment (IHT) in managing painful episodes with the improvement in QoL of CP patients.

Method A pretest–posttest clinical study was conducted on 40 patients with CP. The Numeric Rating Scale (NRS) and Dermatology Life Quality Index (DLQI) were the outcome measures, assessed at baseline and after 2 months of IHT. Modified Naranjo Criteria (MNC) evaluated the possible causal attribution of IHT.

Results There was a statistically significant reduction in pain NRS score (8.89 ± 0.84 vs 2.97 ± 1.17; 95% confidence interval [CI] = 5.44–6.39; p < 0.01) as well as DLQI score (19.35 ± 2.95 vs 3.59 ± 1.99; 95% CI = 15.06–16.45; p < 0.01) among 37 patients. The large effect size derived (4.17) clinically, substantiates the beneficial effects in managing the painful episodes of CP. The MNC scores (7–10) ascertained the likelihood of improvement due to IHT.

Conclusion IHT significantly reduced the pains due to CP and improved the QoL. Further studies are warranted with enhanced methodology.

Keywords

paronychia - homoeopathy - pain - quality of life

Statement of Ethics

Ethical clearance was obtained from IEC, Siliguri (Ref no.: 60/2018–19/CRU(H)/Ethical/Slg/07.08.2018) before initiation of the study and was prospectively registered in the Clinical Trials Registry – India (Trial registration: CTRI-REF/2019/04/025510). Informed consent was taken from all the participants who were part of the study. Necessary measures were taken to ensure the confidentiality and anonymity of patients.




Publication History

Article published online:
29 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Rigopoulos D, Gregoriou S, Belyayeva E, Larios G, Kontochristopoulos G, Katsambas A. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol 2009; 160 (04) 858-860
    CrossrefPubMedGoogle Scholar
  • 2 Dulski A, Edwards CW. Paronychia. [Updated 2020 Aug 10]. [Internet] Treasure Island, FL: StatPearls Publishing; 2021: 20894
    Google Scholar
  • 3 Hochman LG. Paronychia: more than just an abscess. Int J Dermatol 1995; 34 (06) 385-386
    CrossrefPubMedGoogle Scholar
  • 4 ICD-11 for Mortality and Morbidity Statistics. Accessed February 10, 2022. Accessed July 19, 2022 https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/409382263
    PubMedGoogle Scholar
  • 5 Paronychia - Symptoms, diagnosis and treatment | BMJ Best Practice. Accessed July 19, 2022 https://bestpractice-bmj.ccrhlibrary.in/topics/en-gb/350?q=Paronychia&c=recentlyviewed
    PubMedGoogle Scholar
  • 6 Pierrart J, Delgrande D, Mamane W, Tordjman D, Masmejean EH. Acute felon and paronychia: antibiotics not necessary after surgical treatment. Prospective study of 46 patients. Hand Surg Rehabil 2016; 35 (01) 40-43
    CrossrefPubMedGoogle Scholar
  • 7 Jebson PJL. Infections of the fingertip. Paronychias and felons. Hand Clin 1998; 14 (04) 547-555 , viii
    CrossrefPubMedGoogle Scholar
  • 8 Rockwell PG. Acute and chronic paronychia. Am Fam Physician 2001; 63 (06) 1113-1116
    PubMedGoogle Scholar
  • 9 Black JR. Paronychia. Clin Podiatr Med Surg 1995; 12 (02) 183-187
    PubMedGoogle Scholar
  • 10 Bahunuthula RK, Thappa DM, Kumari R, Singh R, Munisamy M, Parija SC. Evaluation of role of Candida in patients with chronic paronychia. Indian J Dermatol Venereol Leprol 2015; 81 (05) 485-490
    CrossrefPubMedGoogle Scholar
  • 11 Belyayeva E, Gregoriou S, Chalikias J. et al. The impact of nail disorders on quality of life. Eur J Dermatol 2013; 23 (03) 366-371
    CrossrefPubMedGoogle Scholar
  • 12 Reich A, Szepietowski JC. Health-related quality of life in patients with nail disorders. Am J Clin Dermatol 2011; 12 (05) 313-320
    CrossrefPubMedGoogle Scholar
  • 13 Bednar MS, Lane LB. Eponychial marsupialization and nail removal for surgical treatment of chronic paronychia. J Hand Surg Am 1991; 16 (02) 314-317
    CrossrefPubMedGoogle Scholar
  • 14 Grover C, Bansal S, Nanda S, Reddy BSN, Kumar V. En bloc excision of proximal nail fold for treatment of chronic paronychia. Dermatol Surg 2006; 32 (03) 393-398 , discussion 398–399
    PubMedGoogle Scholar
  • 15 Ferreira Vieira d'Almeida L, Papaiordanou F, Araújo Machado E, Loda G, Baran R, Nakamura R. Chronic paronychia treatment: square flap technique. J Am Acad Dermatol 2016; 75 (02) 398-403
    CrossrefPubMedGoogle Scholar
  • 16 Rich P. Nail cosmetics. Dermatol Clin 2006; 24 (03) 393-399
    CrossrefPubMedGoogle Scholar
  • 17 Fox PA, Tung MY. Human papillomavirus: burden of illness and treatment cost considerations. Am J Clin Dermatol 2005; 6 (06) 365-381
    CrossrefPubMedGoogle Scholar
  • 18 Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol 2014; 59 (01) 15-20
    CrossrefPubMedGoogle Scholar
  • 19 Herman PM, Craig BM, Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med 2005; 5 (05) 11 DOI: 10.1186/1472.
    CrossrefPubMedGoogle Scholar
  • 20 Mathie RT. The research evidence base for homeopathy: a fresh assessment of the literature. Homeopathy 2003; 92 (02) 84-91 DOI: 10.1016/S1475-4916(03)00006-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Haque S, Das D, Bhattacharya S, Sarkar T, Khuda-Bukhsh AR. Homeopathy - a safe, much less expensive, non-invasive, viable alternative for the treatment of patients suffering from loss of lumbar lordosis. J Pharmacopuncture 2016; 19 (04) 358-361
    CrossrefPubMedGoogle Scholar
  • 22 NABH. NABH Accreditation Standards for Homoeopathy. 2nd edition. New Delhi: NABH; 2016
    Google Scholar
  • 23 Allen HC. Keynotes and Characteristics with Comparison of Some of the Leading Remedies of the Materia Medica with Bowel Nosodes. 15th impression. New Delhi: B Jain Publishers (P) Ltd; 2016
    Google Scholar
  • 24 Boericke W. Boericke's New Manual of Homeopathic Materia Medica with Repertory. 37th edition. New Delhi: B Jain Publishers (P) Ltd;; 2016
    Google Scholar
  • 25 Clarke JH. A Dictionary of Practical Materia Medica. Reprint ed. New Delhi: B Jain Publishers (P) Ltd; 1996
    Google Scholar
  • 26 Kent JT. Lectures on Homoeopathic Materia Medica. Reprint ed. Nee Delhi: B Jain Publishers (P) Ltd.; 2012
    Google Scholar
  • 27 Schroyens F. Repertorium Homeopathicum Syntheticum. Reprint 9. New Delhi: B Jain Publishers (P) Ltd; 2012
    Google Scholar
  • 28 Murphy R. Homeopathic Medical Repertory: A Modern Alphabetical and Practical Repertory. 7th Reprint. New Delhi: B Jain Publishers (P) Ltd; 2009
    Google Scholar
  • 29 PubMed. . Accessed July 19, 2022 https://pubmed.ncbi.nlm.nih.gov/.
    PubMed
  • 30 Homeopathy Research Institute | HRI – CORE-Hom. Accessed July 19, 2022 https://www.hri-research.org/resources/research-databases/core-hom/
    PubMedGoogle Scholar
  • 31 Google Scholar. . Accessed July 19, 2022 https://scholar.google.co.in/citations?user=9-Drb74AAAAJ&hl=en&scioq=google+scholar
    PubMedGoogle Scholar
  • 32 AYUSH RESEARCH PORTAL. . Accessed July 19, 2022 https://ayushportal.nic.in/
    PubMed
  • 33 Archive on Homoeopathy. . Search. Accessed July 19, 2022 http://aohindia.in/jspui/simple-search?query=paronychia
    PubMed
  • 34 Anjana RM, Deepa M, Pradeepa R. et al; ICMR–INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017; 5 (08) 585-596
    CrossrefPubMedGoogle Scholar
  • 35 NAMASTE - Portal.
    PubMed
  • 36 Kent JT. Lectures on Homeopathic Philosophy. 4th Reprint. New Delhi: B Jain Publishers; 1997
    Google Scholar
  • 37 McCaffery M, Beebe A. Pain: Clinical manual for nursing practice. St Louis, MO: Mosby; 1989
    Google Scholar
  • 38 Sloman R, Wruble AW, Rosen G, Rom M. Determination of clinically meaningful levels of pain reduction in patients experiencing acute postoperative pain. Pain Manag Nurs 2006; 7 (04) 153-158
    CrossrefPubMedGoogle Scholar
  • 39 Jesmin A, Sultana A, Saiful M, Bhuiyan I, Arafat SMY. Validation of Bangla Dermatology Life Quality Index among patients with psoriasis. J Pak Assoc Dermatol 2021; 31 (02) 165-172
    PubMedGoogle Scholar
  • 40 Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19 (03) 210-216
    CrossrefPubMedGoogle Scholar
  • 41 Basra MK, Fenech R, Gatt RMSM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159 (05) 997-1035
    PubMedGoogle Scholar
  • 42 Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean?. J Invest Dermatol 2005; 125 (04) 659-664
    CrossrefPubMedGoogle Scholar
  • 43 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
    CrossrefPubMedGoogle Scholar
  • 44 Naranjo CA, Busto U, Sellers EM. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (02) 239-245
    CrossrefPubMedGoogle Scholar
  • 45 Stub T, Salamonsen A, Alraek T. Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forsch Komplement Med 2012; 19 (01) 13-19
    CrossrefPubMedGoogle Scholar
  • 46 Stub T, Kristoffersen AE, Alræk T, Musial F, Steinsbekk A. Risk in homeopathy: Classification of adverse events and homeopathic aggravations–A cross sectional study among Norwegian homeopath patients. Complement Ther Med 2014; 23 (04) 535-543
    CrossrefPubMedGoogle Scholar
  • 47 Choubey G, Nahar L, Banerjee A, Roja V. Role of homoeopathy in the management of adhesive capsulitis: a pretest-posttest study. Indian J Res Homoeopath 2022; 16 (01) 31-40
    CrossrefPubMedGoogle Scholar
  • 48 Mathie RT, Van Wassenhoven M, Rutten ALB. et al. Model validity of randomised placebo-controlled trials of non-individualised homeopathic treatment. Homeopathy 2017; 106 (04) 194-202
    Article in Thieme ConnectPubMedGoogle Scholar